 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced it will report financial results for the first quarter 2024 after market close on Thursday, May 9, 2024...

Guardant Health to Report First Quarter 2024 Financial Results on May 9, 2024

Guardant Health (NASDAQ:GH - Get Free Report)s stock had its "neutral" rating reissued by investment analysts at Guggenheim in a note issued to investors on Friday, Benzinga reports. GH has...

Guggenheim Reaffirms Neutral Rating for Guardant Health (NASDAQ:GH)

This is a signal that GH's price trend could be reversing, and it may be an opportunity to sell the stock or take a defensive position...

Guardant Health (GH, $20.25) Stochastic Oscillator left the overbought zone on April 01, 2024

This price move could indicate a change in the trend, and may be a sell signal for investors...

Guardant Health (GH, $20.25) price exceeded its 50-day Moving Average on April 01, 2024

Investors in Guardant Health Inc (GH) saw new options become available this week, for the June 21st expiration. One of the key data points that goes into the price an option buyer is willing to pay...

First Week of GH June 21st Options Trading

Portman Square Capital LLP decreased its position in Guardant Health, Inc. (NASDAQ:GH - Free Report) by 77.0% in the 4th quarter, according to the company in its most recent filing with the...

Guardant Health, Inc. (NASDAQ:GH) Holdings Reduced by Portman Square Capital LLP

In this article, we will be taking a look at the 2o foods to reduce cancer risk. If you do no want learn about the global and US cancer stats, head straight to the 5 Foods To Reduce Cancer...

20 Foods To Reduce Cancer Risk

Guardant Health, Inc. (NASDAQ:GH - Get Free Report) shares rose 3.9% during trading on Thursday . The stock traded as high as $18.82 and last traded at $18.66. Approximately 453,331 shares were...

Guardant Health (NASDAQ:GH) Trading Up 3.9%

Guardant Health, Inc. (NASDAQ:GH - Get Free Report) saw unusually large options trading on Thursday. Traders purchased 15,891 call options on the stock. This represents an increase of 967% compared...

Guardant Health Target of Unusually Large Options Trading (NASDAQ:GH)

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...

Does Guardant Health (NASDAQ:GH) Have A Healthy Balance Sheet?

Guardant Health, Inc. is a precision oncology company engaged in the treatment of cancer through the use of proprietary blood-based tests, vast data sets, and advanced analytics. Its solutions include treatment selection, recurrence detection, and early detection. The company was founded by Helmy Eltoukhy, AmirAli H. Talasaz, and Michael Joseph Wiley in 2011 and is headquartered in Palo Alto, CA.

Volume (M)	189.00
52-Wk High	$41.06
52-Wk Low	$15.89

GH Guardant Health Inc

About

Feed

News

Sentiment

Earnings

Fundamentals